Skip to main content
Clinical Trials/ITMCTR2000003673
ITMCTR2000003673
Recruiting
Phase 1

Clinical Double-Blind Randomized Controlled Trial of Quji Tongluo Decoction in Intervention of Branch Retinal Vein Occlusion Secondary Macular Edema

Eye Hospital, China Academy of Chinese Medical Sciences0 sitesStarted: TBDLast updated:

Overview

Phase
Phase 1
Status
Recruiting
Sponsor
Eye Hospital, China Academy of Chinese Medical Sciences

Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional study

Eligibility Criteria

Ages
40 to 70 (—)
Sex
All

Inclusion Criteria

  • 1\. Between 40 and 70 years old;
  • 2\. It conforms to the Western medicine diagnostic criteria of non\-ischemic branch retinal vein occlusion and conforms to the TCM syndrome differentiation criteria of phlegm and blood stasis. The course of the disease is more than 2 weeks;
  • 3\. OCT examination showed macular edema, and the thickness of the central retina was more than 250µm;
  • 4\. Agree to participate in this clinical trial and sign an informed consent form.

Exclusion Criteria

  • 1\. There is severe turbidity of the refractive medium;
  • 2\. Those with loss of central vision in the late course of the disease;
  • 3\. Combined with other macular diseases of the retina;
  • 4\. Persons who are allergic or possibly allergic to drugs;
  • 5\. Patients suffering from severe cardiovascular and cerebrovascular diseases or severely impaired liver and kidney function and systemic failure, or combined with severe global diseases, cannot tolerate relevant eye examinations and surgical treatment;
  • 6\. Women during pregnancy and lactation;
  • 7\. Patients who are participating in clinical trials of other drugs or who have used similar Chinese medicines and other treatments.

Investigators

Sponsor
Eye Hospital, China Academy of Chinese Medical Sciences

Similar Trials